Blueshift Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $593K | Buy |
+10,792
| New | +$593K | 0.18% | 149 |
|
|
2025
Q1 | – | Sell |
-5,314
| Closed | -$349K | – | 405 |
|
|
2024
Q4 | $349K | Buy |
+5,314
| New | +$349K | 0.13% | 223 |
|
|
2022
Q4 | – | Sell |
-2,523
| Closed | -$214K | – | 372 |
|
|
2022
Q3 | $214K | Buy |
+2,523
| New | +$214K | 0.05% | 496 |
|
|
2022
Q2 | – | Sell |
-8,243
| Closed | -$636K | – | 700 |
|
|
2022
Q1 | $636K | Buy |
+8,243
| New | +$636K | 0.06% | 365 |
|
|
2021
Q2 | – | Sell |
-10,455
| Closed | -$789K | – | 930 |
|
|
2021
Q1 | $789K | Buy |
+10,455
| New | +$789K | 0.08% | 331 |
|